Interview: Wendy Adams – General Manager, Galderma Canada
Wendy Adams, general manager of Galderma Canada, outlines the main achievements of the affiliate since 2013, the best practices she can share with Galderma globally when it comes to managing…
Galderma is a leading global pharmaceutical company specializing in the research, development and marketing of innovative medical solutions in dermatology. Galderma’s important investments in R&D, extensive product portfolio, global presence and expertise in three key segments (prescription drugs, therapeutic skin care and aesthetic and corrective medical solutions) contribute to maintaining its strong leadership in dermatology. Galderma is committed to delivering innovative medical solutions to meet the dermatological needs of people throughout their lifetime while serving healthcare professionals around the world. The company has 31 wholly-owned affiliates with a worldwide network of distributors and more than 4,000 employees.
Galderma Canada Inc. offers a product portfolio to treat a range of dermatological conditions including: acne, eczema, rosacea, psoriasis and non-melanoma skin cancer.
Strategic brands include:
Tactuo® and Differin® (acne), MetroGel® and Apprilon™ (rosacea), Clobex® (psoriasis), Metvix® (skin cancer), Cetaphil® (therapeutic skin care)
Wendy Adams, general manager of Galderma Canada, outlines the main achievements of the affiliate since 2013, the best practices she can share with Galderma globally when it comes to managing…
Halo Pharma, a US-based one-stop-shop CDMO (Contract Development and Manufacturing Organization), operates out of a site in Mirabel, close to Montreal, that boasts 30 years of experience in developing and…
Boiron Canada is the sixth largest affiliate of Boiron’s global operations (in terms of sales), and under Daniel Dereser’s leadership, the company intends to change the perception of homeopathic medicine…
Introducing Vantage BioTrials, a CRO focused on operational excellence with a lean and holistic approach to each project, Vatché Bartekian, president and co-founder, also advocates for greater visibility for Canada…
Allan O’Dette has been at the helm of the Ontario Investment Office since April 2017. As CIO, he underlines the importance of the life sciences sector in the province, while…
Speaking about the transformation from a pure service provider to true partner, Charles Grubsztajn of Neopharm Labs in Canada highlights the importance of thinking for clients rather than just with…
Whitney Green candidly describes what first surprised him as an American coming to Canada to head up operations as president and general manager of Roche Diagnostics Canada. He highlights the…
Mark Smithyes, president of Labtician Théa, highlights the company’s ambition to become the leader and preferred partner to optometrists and ophthalmologists in Canada by launching products from Laboratoires Théa’s innovative…
Montréal International, the strategic partner for foreign investment, international organizations, and talent, has served the city and surrounding areas for 22 years. Hubert Bolduc, president and CEO, and Christelle Fasano,…
Nadurel Pharma, headquartered in the technopole of Saint–Hyacinthe, Quebec, promotes natural health products complete with concrete clinical trial evidence. Martin Dufour, President and CEO, has been at the helm since…
Jaiveer Singh, CEO of Mint Pharmaceuticals explains the company’s business model and how it fits the characteristics of the Canadian market on the tenth anniversary of the company. He further…
Janet McDougall, president and founder of McDougall Scientific and John Amrhein, vice president in charge of business development, discuss the challenges that SME CROs are facing in Canada today, competing…
Tarik Henein, president of Generic Medical Partners, explains the company’s commitment to improving the lives of Canadians by connecting global generic development and manufacturing companies with the Canadian market. He…
See our Cookie Privacy Policy Here
